Auyeung Diana J, Kessler Fay K, Ritter Joseph K
Department of Pharmacology and Toxicology, Medical College of Virginia Campus of Virginia Commonwealth University, Richmond, Virginia 23298-0613, USA.
Mol Pharmacol. 2003 Jan;63(1):119-27. doi: 10.1124/mol.63.1.119.
The utility of oltipraz as a cancer chemopreventive agent is thought to depend on the induction of enzymes involved in phase 2 xenobiotic detoxification. Although studies of some enzymes induced by oltipraz implicate a novel transcriptional activating pathway involving Nrf2 and antioxidant-response elements (AREs), the mechanism of phenol UGT induction has remained unclear. Previous work showed that UGT1A6 is transcribed from two promoters, P1 and P2, that are both induced by oltipraz in rat liver. The effect also occurs in rat hepatocytes treated with oltipraz (concentrations >3 microM). To investigate the mechanism, luciferase reporter plasmids under the control of P1 [p(-1078/+27)1A6P1-luc] or P2 [p(-1354/+65)1A6P2-luc] were transfected into rat hepatocytes and tested for inducibility. P1, but not P2, showed responsiveness to oltipraz (2- to 5-fold increase) and 3-methylcholanthrene (10- to 30-fold increase). Because P1 contained no visible AREs, the role of a xenobiotic response element (XRE) centered between bases -134 and -129 was evaluated. Mutation of the XRE core reduced the effects of both oltipraz and 3-methylcholanthrene on the P1 reporter. The 1A6 XRE conferred oltipraz responsiveness on the simian virus 40 promoter of pGL3-Promoter. Comparative effects of oltipraz and 3-methylcholanthrene on transfected cytochrome P4501A1 reporters support the general but relatively weak XRE-stimulating activity of oltipraz. The involvement of the aryl hydrocarbon receptor (AHR) and aryl hydrocarbon nuclear translocator (ARNT) in mediating the effects of oltipraz on the XRE is supported by electrophoretic mobility supershift data and AHR/ARNT overexpression studies. These data raise questions about the contribution of AHR and other secondary induction pathways in the mechanism of oltipraz.
奥替普拉作为一种癌症化学预防剂的效用被认为取决于参与Ⅱ相异生物解毒的酶的诱导。尽管对奥替普拉诱导的一些酶的研究表明存在一种涉及Nrf2和抗氧化反应元件(AREs)的新型转录激活途径,但酚类UGT诱导的机制仍不清楚。先前的研究表明,UGT1A6由两个启动子P1和P2转录,这两个启动子在大鼠肝脏中均被奥替普拉诱导。在用奥替普拉(浓度>3 microM)处理的大鼠肝细胞中也会出现这种效应。为了研究其机制,将受P1 [p(-1078/+27)1A6P1-luc]或P2 [p(-1354/+65)1A6P2-luc]控制的荧光素酶报告质粒转染到大鼠肝细胞中,并测试其诱导性。P1而非P2对奥替普拉(增加2至5倍)和3-甲基胆蒽(增加10至30倍)有反应。由于P1中没有可见的AREs,因此评估了位于碱基-134和-129之间的一个异生物反应元件(XRE)的作用。XRE核心的突变降低了奥替普拉和3-甲基胆蒽对P1报告基因的影响。1A6 XRE赋予了pGL3-启动子的猿猴病毒40启动子对奥替普拉的反应性。奥替普拉和3-甲基胆蒽对转染的细胞色素P4501A1报告基因的比较效应支持了奥替普拉普遍但相对较弱的XRE刺激活性。电泳迁移率超迁移数据和AHR/ARNT过表达研究支持芳烃受体(AHR)和芳烃核转运体(ARNT)参与介导奥替普拉对XRE的作用。这些数据引发了关于AHR和其他次要诱导途径在奥替普拉机制中的作用的问题。